Co-Diagnostics Inc (NAS:CODX)
$ 1.36 0.04 (3.03%) Market Cap: 43.40 Mil Enterprise Value: -379,000.00 PE Ratio: 0 PB Ratio: 0.60 GF Score: 51/100

Q2 2024 Co-Diagnostics Inc Earnings Call Transcript

Aug 08, 2024 / 08:30PM GMT
Release Date Price: $1.02 (-4.67%)
Operator

Good day, and welcome to the Co-Diagnostics second quarter 2024 earnings conference call. (Operator Instructions) Please note that this event is being recorded.

I would now like to turn the conference over to Andrew Benson, Head of Investor Relations. Please go ahead.

Andrew Benson
Co-Diagnostics Inc - Head of Investor Relations

Good afternoon, everyone. Thank you all for participating in today's conference call. On the line today from Co-Diagnostics, we have Dwight Egan, Chief Executive Officer; and Brian Brown, Chief Financial Officer.

Earlier today, Co-Diagnostics released financial results from the second quarter ended June 30, 2024. A copy of the press release is available on the company's website. We will begin the call with management's prepared remarks and then open up the call to analyst Q&A.

Before we begin, we would like to inform the listeners that certain statements made by Co-Diagnostics during this call that are not historical facts are forward-looking statements. This includes statements concerning the company's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot